Screening calmodulin-binding ligands using intensity-fading matrix-assisted laser desorption/ionization mass...

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Calmodulin (CaM) regulates critical cellular processes including metabolism, cytoskeleton dynamics, and proliferation.
• CaM antagonists modulate CaM's biological functions by binding to it.
• Identifying novel CaM ligands is crucial for developing targeted anti-cancer therapies.

Purpose of the Study:

• To establish and validate an intensity-fading matrix-assisted laser desorption/ionization mass spectrometry (IF-MALDI-MS) method for screening CaM ligands.
• To identify novel alkaloid compounds that bind to CaM.
• To compare the binding affinities of identified CaM ligands.

Main Methods:

• Developed an IF-MALDI-MS assay using propranolol as an internal standard.
• Optimized MS conditions using known CaM ligands (trifluoperazine, chlorpromazine) and Ca(2+)-CaM.
• Screened eight alkaloids for CaM binding and performed competitive binding experiments to determine relative affinities.

Main Results:

• The IF-MALDI-MS method effectively detected CaM ligands using 2,6-dihydroxyacetophenone (DHAP) as a matrix.
• Six alkaloids (berbamine, tetrandrine, papaverine, reserpine, brucine, tetrahydropalmatine) showed significant binding to CaM.
• Binding affinities were ranked, with tetrandrine exhibiting the highest affinity among the tested alkaloids.

Conclusions:

• The IF-MALDI-MS method provides a robust platform for qualitative and semi-quantitative screening of CaM ligands.
• Identified alkaloids represent potential novel leads for the development of CaM antagonists.
• This approach facilitates the discovery of new therapeutic agents targeting CaM-mediated pathways.